While it is not a common condition, Guillain-Barré Syndrome (GBS) is garnering increased interest from the broader medical diagnostics industry as new cases are reported worldwide each year and linked ...

Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...